Avastin 1 — Class II drug recall D-0248-2025
Completed recall by Turbare Manufacturing, reported 2025-03-05, distributed nationwide. Lack of Assurance of Sterility: due to a quality control process deviation
| Recall number | D-0248-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Completed |
| Voluntary or mandated | Voluntary |
| Recalling firm | Turbare Manufacturing, Conway, AR, United States |
| Recall initiated | 2025-02-18 |
| Classified | 2025-02-21 |
| Reported by FDA | 2025-03-05 |
| Terminated | 2026-02-26 |
| Distributed | Nationwide (US) |
| Quantity | 1,147 syringes |
| Reason classes | sterility |
| NDC | 83556-0101-01 |
| Expiration dates | 2025-03-12, 2025-04-18 |
Product
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Reason for recall
Lack of Assurance of Sterility: due to a quality control process deviation
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0248-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.